Purine derivatives as potent BTK inhibitors for autoimmune diseases

被引：0

作者：

Shi, Qing ^{[1
]}

Liu, Chunjian ^{[1
]}

Lin, James ^{[1
]}

Dyckman, Alaric J. ^{[1
]}

Li, Hedy ^{[1
]}

Vandevier, Lauren E. ^{[1
]}

Cavallaro, Cullen ^{[1
]}

Spergel, Steven ^{[1
]}

Burke, James R. ^{[1
]}

Tebben, Andrew ^{[1
]}

Strnad, Joann ^{[1
]}

Surti, Neha ^{[1
]}

Muckelbauer, Jodi K. ^{[1
]}

Mcintyre, Kim ^{[1
]}

Leftheris, Katerina ^{[1
]}

Carter, Percy H. ^{[1
]}

Tino, Joseph ^{[1
]}

Delucca, George V. ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, New York, NY 10154 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 242卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

316-MEDI

引用

页数：1

共 50 条

[1] Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases
Shi, Qing
Tebben, Andrew
Dyckman, Alaric J.
Li, Hedy
Liu, Chunjian
Lin, James
Spergel, Steve
Burke, James R.
McIntyre, Kim W.
Olini, Gilbert C.
Strnad, Joann
Surti, Neha
Muckelbauer, Jodi K.
Chang, Chiehying
An, Yongmi
Cheng, Lin
Ruan, Qian
Leftheris, Katerina
Carter, Percy H.
Tino, Joseph
De Lucca, George V.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (09) : 2206 - 2211
[2] Nicotinamide derivatives as potent BTK inhibitors for autoimmune diseases
De Lucca, George V.
Shi, Qing
Liu, Chunjian
Tebben, Andrew
Strnad, Joann
Surti, Neha
Muckelbauer, Jodi K.
Mcintyre, Kim
Burke, James R.
Leftheris, Katerina
Carter, Percy H.
Tino, Joseph
Chang, Chiehying
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[3] Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases
Zhang, Datong
Gong, He
Meng, Fancui
[J]. MOLECULES, 2021, 26 (16):
[4] Clinical Research Progress of BTK Inhibitors in the Treatment of Autoimmune Diseases
Lin, Pei
Zhang, Dandan
Lin, Jun
[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (28) : 2609 - 2620
[5] Discovery of pyrazolopyrimidine derivatives as potent BTK inhibitors with effective anticancer activity in MCL
Ran, Fansheng
Liu, Yang
Liu, Meixia
Zhang, Daoguang
Wang, Peng
Dong, Junze
Tang, Wendi
Zhao, Guisen
[J]. BIOORGANIC CHEMISTRY, 2019, 89
[6] Development of potent inhibitors of a critical mediator of autoimmune and inflammatory diseases
Al-Abed, Yousef
Cheng, Kai Fan
Dabideen, Darrin
Ochani, Mahendar
Aljabari, Bayan
Pavlov, Valentin A.
Lolis, Elias
Miller, Edmund J.
[J]. DRUGS OF THE FUTURE, 2007, 32 : 27 - 27
[7] Potent and selective pyridone BTK inhibitors with activity against mutant forms of BTK
Crawford, James
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
[8] Pyrrolidinone Derivatives as NIK Inhibitors for Treating Autoimmune and Inflammatory Diseases
Sabnis, Ram W.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (05): : 581 - 582
[9] Pyrrolidinone Derivatives as NIK Inhibitors for Treating Inflammatory and Autoimmune Diseases
Sabnis, Ram W.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (03): : 322 - 323
[10] Purine derivatives as potent γ-secretase modulators
Rivkin, Alexey
Ahearn, Sean P.
Chichetti, Stephanie M.
Hamblett, Christopher L.
Garcia, Yudith
Martinez, Michelle
Hubbs, Jed L.
Reutershan, Michael H.
Daniels, Matthew H.
Siliphaivanh, Phieng
Otte, Karin M.
Li, Chaomin
Rosenau, Andrew
Surdi, Laura M.
Jung, Joon
Hughes, Bethany L.
Crispino, Jamie L.
Nikov, George N.
Middleton, Richard E.
Moxham, Christopher M.
Szewczak, Alexander A.
Shah, Sanjiv
Moy, Lily Y.
Kenific, Candia M.
Tanga, Flobert
Cruz, Jonathan C.
Andrade, Paula
Angagaw, Minilik H.
Shomer, Nirah H.
Miller, Thomas
Munoz, Benito
Shearman, Mark S.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2279 - 2282

← 1 2 3 4 5 →